The €6.2 Million Glove Tender: Labour Findings Against the Incumbent
Northgate Health Trust runs three hospitals and spends about €48 million a year on consumables. Its tender for single-use surgical gloves and gowns, worth €6.2 million over two years, has drawn four bids. The incumbent, Medisafe, is 11% cheaper than the next bidder, but its last third-party audit found two non-conformities: overtime averaging 72 hours a month at a Malaysian finishing plant, and an undeclared second-tier subcontractor doing packaging. The trust's procurement policy mentions 'value for money' but says nothing about labour standards. The clinical director wants Medisafe retained because glove fit is good and switching risks stock-outs during winter. The finance director refuses any price increase above 3%. A local NGO has written to the board citing the audit. The procurement lead believes Medisafe should be disqualified, but the legal adviser says the tender documents contain no exclusion ground that would survive challenge. The board wants a recommendation in ten days.
1. The board asks whether this is a straight choice between sustainability and value for money. Using ISO 20400's fundamental principles, explain how the procurement lead should frame the decision and who should own it.
Read the worked answer
Frame it as a governance decision, not a contest between 'green' and 'cheap'. ISO 20400 sets out principles - accountability, transparency, ethical behaviour, respect for stakeholder interests, respect for the rule of law, respect for international norms of behaviour and respect for human rights - and expects an organization to identify its significant issues against the core subjects. Here the significant issues are labour practices and human rights in the supply chain.
- Accountability: the decision belongs to the board or an executive risk forum working to a documented risk appetite. A procurement officer cannot weigh a human-rights finding against a clinical supply risk alone.
- Transparency: record the audit findings, the premium, the stock-out risk and the legal advice; publish what can be published.
- Respect for stakeholder interests: clinicians, patients, the Malaysian workers and the NGO all have standing, but not equal weight. The board must show how it weighed them.
- Rule of law: the current tender can only be evaluated on its published terms. Any sustainability action not permitted by those terms must be delivered through contract management or the next tender, not invented at award.
ISO 20400 is guidance, not a certifiable rulebook. The deliverable is a reasoned, documented decision - not a claim that the standard 'requires' exclusion.
2. Can Medisafe lawfully be excluded, and if not, what defensible action remains under ISO 20400's supplier selection guidance?
Read the worked answer
Probably not on this tender. Exclusion must rest on a ground stated in the tender documents or permitted by the applicable procurement law, applied equally to all bidders. The findings are serious, but a late, unpublished exclusion ground is challengeable, and losing a challenge costs more than the premium.
A defensible sequence:
- Check the contract and tender terms. If a code of conduct or audit clause is already incorporated, the findings may be a breach. Use the contractual remedy route rather than exclusion.
- Award on the published criteria, then make a corrective-action plan a condition of mobilisation: independent verification of overtime, disclosure and approval of the sub-tier, repayment of underpaid wages, monthly reporting, and a deadline.
- Use leverage deliberately. The trust is a large buyer. A credible threat of non-renewal plus technical support is usually more effective than immediate exit, which can push workers into worse employment.
- Fix the instrument. The next tender should carry a code of conduct with audit rights down the chain, subcontractor approval, remediation obligations, and clearly stated exclusion or contractual consequences.
- Document the reasoning so an auditor or challenger can see the trust acted consistently rather than arbitrarily.
If the supplier refuses verification altogether, escalation to termination at the contract's lawful exit point becomes defensible.
3. How should the team respond to the finance director's 3% ceiling without diluting the labour-standard concern?
Read the worked answer
Quantify before conceding. The gap is not 11% versus 3%; it is the premium in euros per year against savings the trust can create inside the same category:
- Demand management: glove and gown usage varies by ward. Standardising sizes and removing non-indicated double-gloving can cut volume several percent without clinical harm.
- Aggregation: buying for three hospitals on one call-off with scheduled deliveries usually improves price.
- Specification: not every procedure needs the same barrier performance; a tiered product range can reduce cost.
- Contract design: indexation, volume bands and a two-year extension give the supplier a reason to hold price.
If those measures close the gap, fund the labour remediation within the ceiling and say so. If they do not, the honest position is that the 3% ceiling makes the labour standard unaffordable at current volumes. That is a board decision with a stated consequence: reduce scope, accept a higher price, or accept the risk.
Do not quietly drop the criterion or score it so low that it has no effect. ISO 20400 expects the trade-off to be made transparently, by the level with authority to accept the risk.